|
Exhibit No.
|
|
|
|
IM CANNABIS CORP.
|
|
|
|
(Registrant)
|
|
|
|
|
|
|
Date: August 17, 2026
|
By:
|
/s/ Oren Shuster
|
|
|
Name:
|
Oren Shuster
|
|
|
Title:
|
Chief Executive Officer and Director
|
|
5
|
|
|
Section 1.01 Definitions.
|
5
|
|
9
|
|
|
Section 2.01 Purchase and Sale.
|
9
|
|
Section 2.02 Purchase Price.
|
9
|
|
Section 2.03 Transactions to Be Effected at the Closing
|
9
|
|
Section 2.04 Closing.
|
9
|
|
10
|
|
|
Section 3.01 Organization and Status.
|
10
|
|
Section 3.02 Corporate Power and Authority.
|
10
|
|
Section 3.03 Execution and Binding Obligation.
|
10
|
|
Section 3.04 Corporate and Share Representations of the Corporation
|
10
|
|
Section 3.05 Financial and Tax Representations
|
11
|
|
Section 3.06 Property Representations
|
11
|
|
Section 3.07 No Subsidiaries.
|
11
|
|
Section 3.08 No Conflicts; Consents.
|
12
|
|
Section 3.09 [Reserved]
|
12 |
|
Section 3.10 Legal Proceedings; Governmental Orders.
|
12 |
|
Section 3.11 Employment Matters.
|
12 |
|
Section 3.12 Pre-Closing Reorganization.
|
12 |
|
Section 3.13 Compliance with Laws.
|
13 |
|
Section 3.14 Tax Matters.
|
13 |
|
Section 3.15 No Other Representations and Warranties.
|
13 |
|
14
|
|
|
Section 4.01 Organization and Qualification.
|
14
|
|
Section 4.02 Corporate Power and Authority.
|
14
|
|
Section 4.03 Execution and Binding Obligation
|
14
|
|
Section 4.04 Independent Investigation; No Reliance; As-Is.
|
14 |
|
Section 4.05 The Related Party controls the Purchaser (within the meaning of the Israeli Securities
Law).
|
14 |
|
15
|
|
|
Section 5.01 Vendor’s Covenants.
|
15
|
|
Section 5.02 Mutual Covenants.
|
15 |
|
Section 5.03 Further Assurances.
|
16 |
|
17
|
|
|
Section 6.01 Conditions to Obligations of All Parties
|
17
|
|
Section 6.02 Conditions to Obligations of Purchaser
|
17
|
|
Section 6.03 Conditions to Obligations of Vendor
|
18
|
|
18
|
|
|
Section 7.01 Termination.
|
18 |
|
19
|
|
|
Section 8.01 Expenses.
|
19
|
|
Section 8.02 Vendor’s Survival.
|
19
|
|
Section 8.03 Purchaser’s Survival.
|
19
|
|
Section 8.04 No Post-Closing Termination.
|
19
|
|
Section 8.05 Notices.
|
19
|
|
Section 8.06 Interpretation.
|
20
|
|
Section 8.07 Headings.
|
20
|
|
Section 8.08 Severability.
|
20
|
|
Section 8.09 Entire Agreement.
|
20
|
|
Section 8.10 Successors and Assigns.
|
20
|
|
Section 8.11 No Third-Party Beneficiaries.
|
20
|
|
Section 8.12 Amendment and Modification; Waiver.
|
20
|
|
Section 8.13 Governing Law; Forum.
|
21 |
|
Section 8.14 Specific Performance.
|
21 |
|
Section 8.15 Counterparts.
|
21 |
|
Section 8.16 Independent Legal and Financial Advice.
|
21 |
|
Section 8.17 Securities Law Matters.
|
21 |
|
|
(a) |
At the Closing, the Purchaser shall deliver to the Vendor:
|
|
|
(i) |
Duly executed copy of the share transfer deed concerning the Shares, in the form to be mutually agreed upon between the Purchaser and the Vendor (the “Share Transfer Deed”);
|
|
|
(ii) |
all other agreements, documents, instruments or certificates required to be delivered by the Purchaser at or before the Closing under Section 6.03;
|
|
|
(b) |
At the Closing, the Vendor shall deliver to the Purchaser:
|
|
|
(i) |
Duly executed copy of the Share Transfer Deed;
|
|
|
(ii) |
A share certificate evidencing the ownership of the Shares by the Purchaser, free and clear of all Encumbrances;
|
|
|
(iii) |
An updated share register of the Corporation reflecting the transfer of the Shares to the Purchaser and that the Purchaser holds 100% of the equity interests of the Corporation on a Fully Diluted Basis;
|
|
|
(iv) |
Evidence, in form and substance reasonably satisfactory to the Purchaser, of the release and removal of all Encumbrances set forth in Schedule 3.04 of the Disclosure Schedules; and,
|
|
|
(v) |
A Valid Tax Certificate; and,
|
|
|
(vi) |
All other agreements, documents, instruments or certificates required to be delivered by the Vendor at or before the Closing under Section 6.02.
|
|
|
(a) |
The Shares constitute 100% of the issued and outstanding share capital of the Corporation on a Fully Diluted Basis. There are no outstanding or authorized options, warrants, convertible securities or other rights, agreements, arrangements
or commitments of any character relating to the shares of the Corporation or obligating the Vendor or the Corporation to issue or sell any shares of, or any other interest in, the Corporation. The Corporation does not have outstanding or
authorized any share appreciation, phantom share, profit participation or similar rights. Except as set forth in Schedule 3.04 of the Disclosure Schedule, there are no voting trusts or
agreements, pooling agreements, unanimous shareholder agreements, other shareholder agreements, proxies or other agreements or understandings in effect with respect to the voting or transfer of any of the Shares.
|
|
|
(b) |
The Corporation has the corporate power to own its Assets.
|
|
|
(c) |
The authorized capital of the Corporation consists of 20,000,000 ordinary shares, nominal value NIS 0.01 each, of which the Shares are the only shares of the Corporation issued and outstanding and represent 100% of the equity interests of
the Corporation on a Fully Diluted Basis.
|
|
|
(d) |
The Shares are validly issued and outstanding as fully paid and non-assessable shares in the capital of the Corporation.
|
|
|
(e) |
The Vendor owns the Shares as legal and beneficial owner, free and clear of all Encumbrances, save any Encumbrances to be discharged or released on or before the Closing, and the Shares constitute 100% of the equity interests of the
Corporation on a Fully Diluted Basis.
|
|
|
(f) |
The Vendor has, except for with respect to the Encumbrance referred to in Schedule 3.04 due and sufficient right and authority to enter into this Agreement on the terms and conditions set
forth in this Agreement and to transfer the legal and beneficial title to and ownership of the Shares to the Purchaser.
|
|
|
(g) |
Other than pursuant to this Agreement, no person, firm or corporation has any agreement or option or any right capable of becoming an agreement to purchase or otherwise acquire the Shares or any of the unissued shares in the capital of the
Corporation.
|
|
|
(a) |
Except as set forth in Schedule 3.05(a) of the Disclosure Schedules,
|
|
|
(i) |
There are no Liabilities contingent or otherwise, of the Corporation, which are not disclosed or reflected; provided that, the foregoing shall not apply to any direct Liabilities of the Target Subsidiaries;
|
|
|
(ii) |
To Vendor’s Knowledge, the Corporation has not guaranteed, or agreed to guarantee, any debt, Liability or other obligation of any person, firm or corporation; and
|
|
|
(iii) |
There are no material Liabilities of the Corporation other than the Retained Liabilities prescribed in the Retained Liabilities List provided that, the foregoing shall not apply to any direct Liabilities of the Target Subsidiaries.
|
|
|
(iv) |
For the avoidance of doubt, except as expressly set forth in this ARTICLE III, neither the Vendor nor the Corporation makes any representation or warranty with respect to any Liabilities of any Target Subsidiary, and no cap set forth in
the definitions of Retained Liabilities or Retained Liabilities List applies to any Liabilities of any Target Subsidiary.
|
|
|
(b) |
Except as set forth in Schedule 3.05(c) of the Disclosure Schedules, to Vendor’s Knowledge, the Corporation is not indebted to the Vendor or any Affiliate, officer, director, or employee of
the Corporation.
|
|
|
(c) |
Except as set forth in Schedule 3.05(d) of the Disclosure Schedules, and/or as otherwise referred to under the Pre-Closing Reorganization, neither the Vendor nor any Affiliate, officer,
director, of the Corporation is now indebted or under obligation to the Corporation on any account.
|
|
|
(d) |
Since the date of this Agreement, no dividend or other distribution on any shares in the capital of the Corporation has been made, declared or authorized and the Corporation has neither purchased nor redeemed nor agreed to purchase or
redeem any of the Shares.
|
|
|
(e) |
To the Vendor’s Knowledge, all material transactions of the Corporation have been promptly and properly recorded or filed in or with its respective books and records.
|
|
|
(f) |
The minute books of the Corporation contain records of all the meetings and proceedings of shareholders and directors of the Corporation, except where failure of the Corporation to contain records of all the meetings and proceedings of
shareholders and directors of the Corporation would not result in a Material Adverse Effect.
|
|
|
(a) |
To the Vendor’s Knowledge, except for the Encumbrances set forth in Schedule 3.06(a) of the Disclosure Schedules, the Corporation has good and marketable title to all its Assets, subject to
no Encumbrances, and all such Assets are in good order and repair, except where failure of this representation to be true and correct would not result in a Material Adverse Effect.
|
|
|
(b) |
To the Vendor’s Knowledge, except for the Encumbrances set forth in Schedule 3.06(b) of the Disclosure Schedules, the Corporation has good and valid ownership, leasehold, licensed or other
appropriate rights, as applicable, to the Assets, and the Assets comprise all of the direct or indirect equity interests in the Target Subsidiaries held by the Corporation following completion of the Pre-Closing Reorganization.
|
|
|
(a) |
To Vendor’s Knowledge, there are no actions, suits, claims, investigations or other legal proceedings pending or, threatened against or by the Corporation affecting any of its properties or Assets (or by or against the Vendor or any
Affiliate thereof and relating to the Corporation), which if determined adversely to the Corporation (or to the Vendor or any Affiliate thereof) would result in a Material Adverse Effect.
|
|
|
(b) |
To Vendor’s Knowledge, there are no outstanding Governmental Orders and no unsatisfied judgments, penalties or awards against or affecting the Corporation or any of its properties or Assets which would have a Material Adverse Effect.
|
|
|
(a) |
Consents. Use all reasonable efforts to assist the Purchaser in obtaining from all appropriate federal, provincial, state, municipal and other governmental or administrative bodies and all other
persons all such approvals and consents in form and terms satisfactory to counsel for the Purchaser as are necessary or required in order to permit the sale, transfer and assignment of all of the right, title and interest of the Vendor in and
to the Shares to the Purchaser.
|
|
|
(b) |
Possession. Deliver to the Purchaser possession of all books, records, book accounts, lists of suppliers and customers of the Corporation and all other documents, files, records and other data,
financial or otherwise, relating to the Corporation, the Target Subsidiaries and the Retained Liabilities.
|
|
|
(c) |
Diligence. At any time after the date of this Agreement or the date on which the Purchaser deliver a notice to the Vendor that it has completed its due diligence, whichever is earlier, the Vendor
will permit the Purchaser, and its auditors, solicitors and other authorized persons, to make such investigation of the Assets and of its financial and legal condition as the Purchaser deems necessary or advisable to familiarize itself with
such Assets and other matters, and the Vendor will and will cause the Corporation to execute any consents or other approvals required by the Purchaser to complete such investigations as the Purchaser may require, and to have full access to
the Israeli Operations premises and to all records, documents and other information related to the Israeli Operations and the Corporation.
|
|
|
(d) |
Pre-Closing Reorganization. Complete the Pre-Closing Reorganization.
|
|
|
(a) |
Interim Management – Positive Covenants.
|
|
|
(i) |
carry on the Corporation in the Ordinary Course, in a prudent, business like and efficient manner and substantially in accordance with the procedures and practices in effect on the date of this Agreement;
|
|
|
(ii) |
maintain insurance on the Assets as they are insured on the date of this Agreement;
|
|
|
(iii) |
use all reasonable efforts to preserve and maintain the goodwill of the Israeli Operations; and
|
|
|
(iv) |
do all necessary repairs and maintenance to the Assets and take reasonable care to protect and safeguard those Assets.
|
|
|
(b) |
Interim Management – Negative Covenants.
|
|
|
(i) |
purchase or sell, consume or otherwise dispose of any of the Shares or its rights in the Target Subsidiaries;
|
|
|
(ii) |
enter into any contract or assume or incur any liability except with the knowledge of the Related Party and in the Ordinary Course of business and which is not material;
|
|
|
(iii) |
settle any account receivable of a material nature at less than face value net of the reserve for that account;
|
|
|
(iv) |
waive or surrender any material right;
|
|
|
(v) |
discharge, satisfy or pay any mortgage, pledge, deed of trust, lien, claim, encumbrance, charge, obligation or liability except in the Ordinary Course of business;
|
|
|
(vi) |
distribute cash or assets to any directors, officer, employee or shareholder of the Corporation except with the knowledge of the Related Party and in the Ordinary Course of business; or
|
|
|
(vii) |
make any capital expenditure or commitment for any capital expenditure.
|
|
|
(c) |
Valid Tax Certificate. Vendor shall prepare, file and pursue the application for the Valid Tax Certificate, including by submitting a request to the ITA in a form agreed between the Vendor and the
Purchaser, and use commercially reasonable efforts to obtain such Valid Tax Certificate as promptly as practicable.
|
|
|
(d) |
Registrar; Share Transfer Filings. Cooperate and use its commercially reasonable efforts to make, as promptly as practicable, all filings, notices and registrations required to give effect to, and
to register, the transfer of the Shares with the Israeli Registrar of Companies and any other applicable Israeli Governmental Authority, and shall execute and deliver all such instruments of transfer and other documents as may be required for
that purpose.
|
|
|
(e) |
Closing Conditions. From the date hereof until the Closing Date, each Party hereto (including for such purpose, the Related Party), shall, and the Vendor shall cause the Corporation to, use
commercially reasonable efforts to take such actions as are necessary to expeditiously satisfy the closing conditions set forth in ARTICLE VI.
|
|
|
(f) |
Public Announcements. Unless otherwise required by applicable Law, the rules of any stock exchange (including Nasdaq) (based upon the reasonable advice of counsel) or Securities Law, no Party shall
make any public announcement in respect of this Agreement or the transactions contemplated hereby without the prior written consent of the other Party (such consent not to be unreasonably withheld or delayed), and the Parties shall co-operate
as to the timing and contents of any such announcement. Notwithstanding the foregoing, the Parties acknowledge that the Vendor is a United States and Canadian reporting issuer and a Nasdaq-listed company and will be required to make
disclosure regarding this Agreement and the transactions contemplated hereby in accordance with applicable Securities Laws, including MI 61-101 and the rules of Nasdaq.
|
|
|
(a) |
Following the Closing, each of the Parties shall, and shall cause their respective Affiliates to, execute and deliver such additional documents, instruments, conveyances and assurances, and take such further actions as may be reasonably
required to carry out the provisions hereof and give effect to the transactions contemplated by this Agreement. For the avoidance of doubt, neither the Closing nor any action taken pursuant to this Agreement shall release, terminate or
materially impair any guarantee provided by the Related Party to any entity comprising the Israeli Operations, solely with respect to the guarantees, indemnities, suretyships and other credit support set forth in Schedule5.03, which schedule sets forth an exhaustive list of all such arrangements in effect with respect to the Israeli Operations, and any such obligations shall not, by virtue of this transaction, be adversely
affected. Without derogating from the foregoing, the indemnification agreement between the Vendor and the Related Party dated February 1, 2024 shall continue in full force and effect in accordance with its terms following the Closing and
shall apply in full to all guarantees set forth in such Schedule 5.03, and none of the Vendor, the Purchaser, the Corporation or any of their respective Affiliates shall take, omit to take, or
permit any action that would limit, impair, terminate or adversely affect the Related Party’s rights or protections thereunder. Without limiting any other rights of the Related Party, the Vendor hereby irrevocably undertakes that, if any
asset forming part of the Israeli Operations is transferred, assigned, conveyed or otherwise disposed of, or if any equity interests in, or all or any material part of, the Israeli Operations are sold, transferred or otherwise disposed of, in
each case in connection with which the respective guarantee of the Related Party in connection with such part of the Israeli Operations which is contemplated to be so transferred, is then outstanding, such transfer, assignment, conveyance,
disposal or sale shall be expressly conditioned upon the full, final and unconditional release of the Related Party from each such guarantee, indemnity, suretyship or other credit support in form and substance reasonably satisfactory to the
Related Party, unless otherwise agreed by the Related Party, effective concurrently with or prior to the consummation of such transaction. The Purchaser shall exercise all voting rights, consent rights, control rights and other powers
available to it, and shall cause its Affiliates and the relevant entities comprising the Israeli Operations to take all actions necessary, to procure such release, and the Purchaser shall not, and shall cause its Affiliates and the relevant
entities comprising the Israeli Operations not to, consummate, permit or authorize any such transaction unless and until such release has been obtained. Except for enforcing their rights under this Agreement, neither the Purchaser nor the
Related Party shall (and cause any of its Affiliates to refrain from), challenge, bring any claims, and/or otherwise participate in or assisting any plaintiff in connection with such claims, against the Vendor and/or the Corporation in
connection with the validity of the Pre-Closing Reorganization.
|
|
|
(b) |
Trade Name Use. The Parties acknowledge and agree that each of the Purchaser, the Vendor, the Corporation and each Target Subsidiary will, following the Closing, in the conduct of its business, receive a non-exclusive right to use
the name “IMC” as a trade name, trademark, service mark, brand or other business identifier, provided that such use shall adhere to standard procedures and arrangements mutually agreed between the Parties, including that neither Party shall
associate or link its use of the other Party's name with the activities or business of the other Party.
|
|
|
(a) |
the completion of the Pre-Closing Reorganization;
|
|
|
(b) |
the receipt of the Valid Tax Certificate;
|
|
|
(c) |
no Governmental Authority shall have enacted, issued, promulgated, enforced or entered any Law or Governmental Order which is in effect and has the effect of making the transactions contemplated by this Agreement illegal or otherwise
restraining or prohibiting consummation of such transactions; and
|
|
|
(d) |
all other consents, authorizations, orders and approvals from the Governmental Authorities and other Persons referred to in Section 3.08 and Section 4.02 shall have been obtained, in each case in form and substance reasonably satisfactory
to the Parties, and no such consent, authorization, order or approval shall have been revoked.
|
|
|
(a) |
the representations and warranties of the Vendor set out in ARTICLE III, as qualified by the Disclosure Schedules and the terms herein, shall be true and correct in all respects as of the Closing Date with the same effect as though made at
and as of such date (except those representations and warranties that address matters only as of a specified date, which shall be true and correct in all respects as of that specified date);
|
|
|
(b) |
the Vendor shall have duly performed and complied in all material respects with all agreements, covenants and conditions required by this Agreement to be performed or complied with by it before or on the Closing Date, including completion
of the Pre-Closing Reorganization;
|
|
|
(c) |
the Vendor shall have obtained all regulatory approvals required in connection with the purchase and sale of the Shares pursuant to this Agreement, including, but not limited to, any approvals or consents required by applicable Securities
Laws;
|
|
|
(d) |
the Retained Liabilities List shall have been finalized and agreed to by the Parties;
|
|
|
(e) |
since the date of this Agreement, there shall not have occurred any Material Adverse Effect on the Corporation (other than as a result of the Pre-Closing Reorganization);
|
|
|
(f) |
the Purchaser shall have received a certificate, dated the Closing Date and signed by a duly authorized officer of the Vendor, and in the form satisfactory to the Purchaser, that each of the conditions set forth in Section 6.02 (a) and
Section 6.02(b) has been satisfied; and
|
|
|
(g) |
the Vendor shall have delivered, or caused to be delivered, the Share Transfer Deed, free and clear of Encumbrances, duly endorsed in blank or accompanied by share transfers or other instruments of transfer duly executed in blank, together
with the share register of the Corporation reflecting the transfer of the Shares to the Purchaser.
|
|
|
(a) |
the representations and warranties of the Purchaser set out in ARTICLE IV shall be true and correct in all respects as of the Closing Date with the same effect as though made at and as of such date (except those representations and
warranties that address matters only as of a specified date, which shall be true and correct in all respects as of that specified date);
|
|
|
(b) |
the Purchaser shall have duly performed and complied in all material respects with all agreements, covenants and conditions required by this Agreement to be performed or complied with by it before or on the Closing Date;
|
|
|
(c) |
the Special Committee shall have approved the transactions contemplated hereby and shall not have withdrawn or adversely modified such approval;
|
|
|
(D) |
the Vendor shall have received a certificate, dated the Closing Date and signed by a duly authorized officer of the Purchaser and in the form satisfactory to the Vendor, that each of the conditions set forth in Section 6.03(a) and Section
6.03(b) has been satisfied.
|
|
If to Vendor
|
3606 - 833 Seymour Street, Vancouver, British Columbia V6B 0G4
|
|
|
Email:
|
||
|
Attention:
|
Oz Adler, Chairperson
|
|
|
with a copy to (which shall not constitute notice):
|
Sullivan & Worcester Tel Aviv (Har-Even & Co.)
|
|
|
Email:
|
||
|
Attention:
|
Adv. Tamir Chagal
|
|
|
If to Purchaser
|
, Israel
|
|
|
Email:
|
||
|
with a copy to (which shall not constitute notice):
|
Naschitz Brandes Amir & Co. Advocates
|
|
|
Email:
|
||
|
Attention:
|
Ido Erlich
|
|
|
Witness:
|
/s/ Oren Shuster
Name: Oren Shuster
|
|
|
• |
IMC's historical audited financial statements for the period ended June 30, 2026; and
|
|
|
• |
the historical financial statements of IMC Holdings for the period ended June 30, 2026.
|
|
|
IM Cannabis
Corp. |
IMC Holding Ltd.
|
Transaction
Accounting Adjustments |
Pro Forma
|
||||||||||||
|
Assets
|
||||||||||||||||
|
Current Assets:
|
||||||||||||||||
|
Cash and cash equivalents
|
$
|
1,617
|
$
|
(407
|
)
|
$
|
-
|
$
|
1,210
|
|||||||
|
Restricted cash deposit
|
124
|
-
|
-
|
124
|
||||||||||||
|
Trade receivables
|
6,858
|
(1,886
|
)
|
-
|
4,972
|
|||||||||||
|
Other current assets
|
4,848
|
(2,483
|
)
|
-
|
2,365
|
|||||||||||
|
Inventory
|
2,857
|
(1,192
|
)
|
-
|
1,665
|
|||||||||||
|
|
||||||||||||||||
|
Total Current Assets
|
16,304
|
(5,968
|
)
|
-
|
10,336
|
|||||||||||
|
|
||||||||||||||||
|
Non-current assets:
|
||||||||||||||||
|
Investments in affiliate
|
1,975
|
(1,975
|
)
|
-
|
-
|
|||||||||||
|
Property, plant and equipment, net
|
3,652
|
(3,236
|
)
|
-
|
416
|
|||||||||||
|
Intangible assets, net
|
458
|
-
|
-
|
458
|
||||||||||||
|
Goodwill
|
2,073
|
-
|
-
|
2,073
|
||||||||||||
|
Right-of-use assets, net
|
230
|
(140
|
)
|
-
|
90
|
|||||||||||
|
|
||||||||||||||||
|
Total Non-current Assets
|
8,388
|
(5,351
|
)
|
-
|
3,037
|
|||||||||||
|
|
||||||||||||||||
|
Total Assets
|
$
|
24,692
|
$
|
(11,319
|
)
|
-
|
$
|
13,373
|
||||||||
|
|
||||||||||||||||
|
Liabilities
|
||||||||||||||||
|
Current liabilities:
|
||||||||||||||||
|
Current maturities of operating lease liabilities
|
$
|
174
|
$
|
(96
|
)
|
$
|
-
|
$
|
78
|
|||||||
|
Trade payables
|
8,472
|
(2,195
|
)
|
-
|
6,277
|
|||||||||||
|
Other current liabilities
|
7,728
|
(4,748
|
)
|
-
|
2,980
|
|||||||||||
|
Overdraft and credit from bank institutions and others
|
11,404
|
(7,057
|
)
|
-
|
4,347
|
|||||||||||
|
Convertible debentures
|
-
|
-
|
-
|
-
|
||||||||||||
|
Convertible promissory notes
|
1,576
|
-
|
-
|
1,576
|
||||||||||||
|
Derivative warrants liabilities and prefunded warrants
|
12
|
-
|
-
|
12
|
||||||||||||
|
|
||||||||||||||||
|
Total Current liabilities
|
29,366
|
(14,096
|
)
|
-
|
15,270
|
|||||||||||
|
|
||||||||||||||||
|
Non-current liabilities:
|
||||||||||||||||
|
Operating lease liabilities
|
17
|
(12
|
)
|
-
|
5
|
|||||||||||
|
Credit from bank institutions and others
|
661
|
-
|
-
|
661
|
||||||||||||
|
Deferred tax liabilities
|
277
|
(258
|
)
|
-
|
19
|
|||||||||||
|
|
||||||||||||||||
|
Total Non-current liabilities
|
955
|
(270
|
)
|
-
|
685
|
|||||||||||
|
|
||||||||||||||||
|
Total Liabilities
|
$
|
30,321
|
$
|
(14,366
|
)
|
$
|
-
|
$
|
15,955
|
|||||||
|
|
||||||||||||||||
|
Shareholders’ Deficit:
|
||||||||||||||||
|
Share capital and premium
|
$
|
274,847
|
$
|
(46,889
|
)
|
$
|
-
|
$
|
227,958
|
|||||||
|
Capital reserve from share-based payment transactions
|
475
|
-
|
-
|
475
|
||||||||||||
|
Amount received on account of financial instrument and other
|
2,062
|
-
|
-
|
2,062
|
||||||||||||
|
Capital reserve from translation differences of foreign operations
|
(3,345
|
)
|
-
|
-
|
(3,345
|
)
|
||||||||||
|
Capital reserve from transaction with non-controlling interests
|
(2,872
|
)
|
-
|
-
|
(2,872
|
)
|
||||||||||
|
Capital reserve from transaction with controlling shareholder
|
33
|
-
|
-
|
33
|
||||||||||||
|
Accumulated deficit
|
(276,739
|
)
|
49,936
|
-
|
(226,803
|
)
|
||||||||||
|
|
(5,539
|
)
|
3,047
|
-
|
(2,492
|
)
|
||||||||||
|
Non-controlling interests
|
(90
|
)
|
-
|
-
|
(90
|
)
|
||||||||||
|
|
||||||||||||||||
|
Total Shareholders’ Deficit:
|
(5,629
|
)
|
3,047
|
-
|
(2,582
|
)
|
||||||||||
|
|
||||||||||||||||
|
Total Liabilities and Shareholders’ Deficit
|
$
|
24,692
|
$
|
(11,319
|
)
|
-
|
$
|
13,373
|
||||||||
|
|
IM Cannabis
Corp. |
IMC
Holding
Ltd.
|
Transaction
Accounting Adjustments |
Pro Forma
|
||||||||||||||
|
Revenues
|
$
|
16,268
|
$
|
(8,466
|
)
|
$
|
-
|
$
|
7,802
|
|||||||||
|
|
||||||||||||||||||
|
Cost of goods sold
|
13,344
|
(7,389
|
)
|
-
|
5,955
|
|||||||||||||
|
|
||||||||||||||||||
|
Gross profit (loss)
|
2,924
|
(1,077
|
)
|
-
|
1,847
|
|||||||||||||
|
|
||||||||||||||||||
|
General and administrative expenses
|
3,764
|
(1,939
|
)
|
316
|
3(a)
|
|
2,141
|
|||||||||||
|
Sales and marketing
|
2,926
|
(551
|
)
|
-
|
2,375
|
|||||||||||||
|
|
||||||||||||||||||
|
Operating profit (loss)
|
(3,766
|
)
|
1,413
|
(316
|
)
|
(2,669
|
)
|
|||||||||||
|
|
||||||||||||||||||
|
Finance expenses, net
|
(3,174
|
)
|
1,564
|
-
|
(1,610
|
)
|
||||||||||||
|
|
||||||||||||||||||
|
Profit (loss) before income taxes
|
(6,940
|
)
|
2,977
|
(316
|
)
|
(4,279
|
)
|
|||||||||||
|
Income tax benefit
|
(88
|
)
|
-
|
-
|
(88
|
)
|
||||||||||||
|
|
||||||||||||||||||
|
Net loss
|
(6,852
|
)
|
2,977
|
(316
|
)
|
(4,191
|
)
|
|||||||||||
|
Attributable to:
|
||||||||||||||||||
|
Equity holders of the Company
|
(6,638
|
)
|
2,977
|
(316
|
)
|
(3,977
|
)
|
|||||||||||
|
Non-controlling interests
|
(214
|
)
|
-
|
-
|
(214
|
)
|
||||||||||||
|
|
||||||||||||||||||
|
|
(6,852
|
)
|
2,977
|
(316
|
)
|
(4,191
|
)
|
|||||||||||
|
|
||||||||||||||||||
|
Weighted average number of shares (basic and diluted)
|
7,753,651
|
7,753,651
|
||||||||||||||||
|
|
||||||||||||||||||
|
Basic and diluted loss per share attributable to equity holders of the Company
|
$
|
(0.85
|
)
|
$
|
(0.51
|
)
|
||||||||||||
|
|
IM Cannabis
Corp. |
IMC Holding Ltd.
|
Transaction
Accounting Adjustments |
Pro Forma
|
||||||||||||||
|
Revenues
|
$
|
54,731
|
$
|
(36,132
|
)
|
$
|
-
|
$
|
18,599
|
|||||||||
|
|
||||||||||||||||||
|
Cost of goods sold
|
45,045
|
(30,756
|
)
|
-
|
14,289
|
|||||||||||||
|
|
||||||||||||||||||
|
Gross profit (loss)
|
9,686
|
(5,376
|
)
|
-
|
4,310
|
|||||||||||||
|
|
||||||||||||||||||
|
General and administrative expenses
|
9,516
|
(4,889
|
)
|
2,737
|
3(b)
|
|
7,364
|
|||||||||||
|
Sales and marketing
|
5,356
|
(1,139
|
)
|
-
|
4,217
|
|||||||||||||
|
Other expenses
|
6,387
|
(997
|
)
|
-
|
5,390
|
|||||||||||||
|
Share-based compensation
|
14
|
-
|
-
|
14
|
||||||||||||||
|
|
||||||||||||||||||
|
Operating profit (loss)
|
(11,587
|
)
|
1,649
|
(2,737
|
)
|
(12,675
|
)
|
|||||||||||
|
|
||||||||||||||||||
|
Finance expenses, net
|
(71
|
)
|
(2,759
|
)
|
-
|
(2,830
|
)
|
|||||||||||
|
|
||||||||||||||||||
|
Profit (loss) before income taxes
|
(11,658
|
)
|
(1,110
|
)
|
(2,737
|
)
|
(15,505
|
)
|
||||||||||
|
Income tax benefit (expense)
|
(92
|
)
|
-
|
-
|
(92
|
)
|
||||||||||||
|
|
||||||||||||||||||
|
Net loss
|
(11,750
|
)
|
(1,110
|
)
|
(2,737
|
)
|
(15,597
|
)
|
||||||||||
|
Attributable to:
|
||||||||||||||||||
|
Equity holders of the Company
|
(11,319
|
)
|
(1,110
|
)
|
(2,737
|
)
|
(15,166
|
)
|
||||||||||
|
Non-controlling interests
|
(431
|
)
|
-
|
-
|
(431
|
)
|
||||||||||||
|
|
||||||||||||||||||
|
(11,750
|
)
|
(1,110
|
)
|
(2,737
|
)
|
(15,597
|
)
|
|||||||||||
|
|
||||||||||||||||||
|
Weighted average number of shares (basic and diluted)
|
4,241,321
|
4,241,321
|
||||||||||||||||
|
|
||||||||||||||||||
|
Basic and diluted loss per share attributable to equity holders of the Company
|
$
|
(2.67
|
)
|
$
|
(3.58
|
)
|
||||||||||||
|
|
●
|
The Company’s unaudited consolidated statement of financial position as of June 30, 2026, and the related notes, included as Exhibit 99.2 to the Company’s Report of Foreign Private
Issuer on Form 6-K furnished with the U.S. Securities and Exchange Commission on August 13, 2026.
|
|
|
●
|
The Company’s unaudited interim consolidated statement of comprehensive loss for the six months ended June 30, 2026, and the related notes, included as Exhibit 99.2 to the Company’s Report
of Foreign Private Issuer on Form 6-K furnished with the U.S. Securities and Exchange Commission on August 13, 2026.
|
|
|
(a)
|
Represents expenses in the amount of C$316 thousand previously provided by IMC Holding to the Company that were previously eliminated in the consolidated financial statements under the previously consolidated
financials.
|
|
(b)
|
Represents expenses in the amount of C$2,737 thousand previously provided by IMC Holding to the Company that were previously eliminated in the consolidated financial statements under the
previously consolidated financials.
|
|
|
IM Cannabis Corp.
|
IMC Holding Ltd.
|
Transaction
Accounting Adjustments |
Pro Forma
|
||||||||||||
|
Pro forma net loss (in thousands)
|
6,852
|
(2,977
|
)
|
316
|
4,191
|
|||||||||||
|
Weighted average outstanding shares (basic and diluted)
|
7,753,651
|
7,753,651
|
||||||||||||||
|
Basic and diluted loss per ordinary share attributable to equity holders of IMC
|
$
|
0.85
|
$
|
0.51
|
||||||||||||